A haircutting appliance comprises an enclosed housing having a hollow handle connecting the housing to a vacuum source to carry away cut hairs from a subject's head.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8172765 | Method of assessment of airway variability in airway hyperresponsiveness The invention relates to a method of assessing airway variability in airway responsiveness or asthma by measuring the variation of resistance (Rrs) by a forced oscillation technique utilizing either a single or a plurality of input frequencies during a plurality of ... | 05/08/2012 |
| 8163942 | Salt of (2S, 3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl]carbamoyl]oxirane-2-carboxylic acid The invention relates to purification of (2S,3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl]carbamoyl]oxirane-2-carboxylic acid [hereinafter, referred to as the carboxylic acid] using the salt of the carboxylic acid with an organic amine selected from the group consis... | 04/24/2012 |
| 8163917 | Azaindoles useful as inhibitors of Janus kinases The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatm... | 04/24/2012 |
| 8163772 | Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide are described herein, including crystalline forms thereof. ... | 04/24/2012 |
| 8158675 | Compounds and methods for the treatment or prevention of infections Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, Y1, and Z are as defined herein, are useful for treating flaviv... | 04/17/2012 |
| 8153211 | Ink-jet-printable decorative paper Decorative paper for decorative coating materials comprising a base paper and an ink receiving layer dyed in such a way that the decorative paper has after impregnation with impregnating resins and pressing as laminate the same coloring as the coloring of a laminate... | 04/10/2012 |
| 8143224 | Oxidant resistant apolipoprotein A-1 and mimetic peptides A purified polypeptide includes an ApoA1 mimetic or fragment thereof that are resistant to oxidation. ... | 03/27/2012 |
| 8129387 | Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors The present invention relates to substituted 5,6-dihydroimidazo[1,5-f]pteridines of formula I: which are useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprisin... | 03/06/2012 |
| 8110553 | Methods and compositions for the treatment of gastrointestinal disorders The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's di... | 02/07/2012 |
| 8101767 | Modulators of ATP-binding cassette transporters The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to metho... | 01/24/2012 |
| 8101579 | Methods and compositions for the treatment of gastrointestinal disorders Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, u... | 01/24/2012 |
| 8080526 | Methods and compositions for the treatment of gastrointestinal disorders The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's di... | 12/20/2011 |
| 8076357 | Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Pharmaceutical compositions including N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1) and methods of using such compositions are described herein. ... | 12/13/2011 |
| 8067450 | Thiazolidinedione analogues for the treatment of metabolic diseases The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. Formula (I), wherein: each of R1 and R4 is independently selected from H, halo, aliphatic, and alkoxy, ... | 11/29/2011 |
| 8067436 | c-Met modulators and methods of use The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazo... | 11/29/2011 |
| 8044062 | Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds. ... | 10/25/2011 |
| 8039475 | Co-crystals and pharmaceutical compositions comprising the same The invention relates to compositions and co-crystals each comprising (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c... | 10/18/2011 |
| 8003685 | Thiophene analogues for the treatment or prevention of flavivirus infections Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, and Z are as defined herein, are useful for treating flaviviridae viral infections. ... | 08/23/2011 |
| 8003660 | Modulators of muscarinic receptors The present invention relates to benzo-spiro-azaheterocyclic compounds of formula I, wherein R1, R2a, Rsb, R3, R′3, R4, R′4, m, n, q and p are define herein. The compounds of this inven... | 08/23/2011 |
| 7989622 | Phosphatidylinositol 3-kinase inhibitors and methods of their use The present invention comprises small molecule inhibitors of phosphatidylinositol 3-kinase (PI3K), which is associated with a number of malignancies such as ovarian cancer, cervical cancer, breast cancer, colon cancer, rectal cancer, and glioblastomas, among others.... | 08/02/2011 |
| 7985769 | Compounds and methods for the treatment or prevention of infections The present invention provides novel compounds represented by formula I: or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection. ... | 07/26/2011 |
| 7985762 | Inhibitors of serine proteases The present invention relates to compounds of formula I: or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3—NS4A protease. | 07/26/2011 |
| 7977345 | c-MET modulators and method of use A compound for modulating kinase activity according to Formula I, or a pharmaceutically acceptable salt thereof, Wherein J1, J2, J3, R2, J4, Z, Ar and R3 are... | 07/12/2011 |
| 7973162 | Modulators of muscarinic receptors The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. ... | 07/05/2011 |
| 7964624 | Inhibitors of serine proteases The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease. ... | 06/21/2011 |
| 7960544 | Useful indole compounds Indoles that have activity as inhibitors of FAAH are described as are indoles and indole derivatives that have activity as inhibitors of DAO. ... | 06/14/2011 |
| 7951929 | Insecticidal compounds and methods for selection thereof A series of potent and highly specific insecticidal toxins characterized by an amino acid sequences SEQ ID NO: 2-35. ... | 05/31/2011 |
| 7910546 | Methods and compositions for the treatment of gastrointestinal disorders The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogas... | 03/22/2011 |
| 7880060 | Insecticidal polynucleotides and methods of use thereof A family of insecticidal polypeptides expressed in the venom gland of spiders of the genera Atrax and Hadronyche have been described. Also included are polynucleotides and expression vectors encoding the polypeptides and insect viruses and cells expres... | 02/01/2011 |
| 7880007 | Bicyclic substituted phenyl piperidine modulators of muscarinic receptors The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. ... | 02/01/2011 |
| 7879834 | Spiroindoline modulators of muscarinic receptors The present invention relates to spiroindoline modulators of muscarinic receptors. The present invention also provides compositions comprising such spiroindoline modulators, and methods therewith for treating muscarinic receptor mediated diseases. ... | 02/01/2011 |
| 7863449 | Modulators of muscarinic receptors The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. ... | 01/04/2011 |
| 7858790 | Modulators of muscarinic receptors The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. ... | 12/28/2010 |
| 7858635 | Spiro compounds as modulators of muscarinic receptors The present invention relates to spiro compounds of formula XX as modulators of muscarinic receptors, wherein R1, R2, R3, Z1, Z2, L, G, n, m, t and p are defined herein. The present invention also provides compo... | 12/28/2010 |
| 7834200 | Processes and intermediates The invention relates to processes and compounds useful for producing modified aspartic acid derivatives, such as aspartic acid aldehyde moieties. Aspartic acid derivatives are useful for preparing caspase inhibitors and/or prodrugs thereof. ... | 11/16/2010 |
| 7827927 | Anchoring system for watercraft vessels An anchoring system for a watercraft vessel, the anchoring system including an anchor bracket configured to be mountable on the watercraft vessel; a sleeve attached to the anchor bracket, the sleeve having an aperture disposed longitudinally therethrough; a sliding ... | 11/09/2010 |
| 7820671 | Peptidomimetic protease inhibitors The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective ... | 10/26/2010 |
| 7807647 | Methods and compositions for cancer therapy The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers. ... | 10/05/2010 |
| 7794994 | Enzyme-based system and sensor for measuring acetone Described are enzyme systems specific for acetone and methods of using these enzyme systems to detect acetone in biological or environmental samples. Biosensors containing these enzyme systems are disclosed, in which detection of acetone may be achieved by linking e... | 09/14/2010 |
| 7786308 | Muscarinic modulators The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. ... | 08/31/2010 |